DLX6 and prostate cancer: Taken together, we provide evidence demonstrating that silencing of DLX6-AS1 played a regulatory role in reducing the prostate cancer cell proliferation, invasion, and lymph node metastasis by inhibiting the DNMT1-mediated LARGE methylation.